More News
Want to Read Locked Articles?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
September 2024 Ophthalmic News Briefs
Author: Market Scope
Bausch + Lomb is working with Goldman Sachs to explore a sale of the company, the Financial Times reported Sept. 14, with private equity the most likely buyer. The move is being evaluated as a way for Bausch + Lomb to finally separate from its parent, Canada’s Bausch Health. Separation got underway in August 2020 when Bausch Health said it would spin off Bausch + Lomb into a separate publicly traded company. Bausch + Lomb conducted an initial public offering in May 2022 and started trading on...
